Celltrion
068270.KS
#761
Rank
S$36.10 B
Marketcap
$167.76
Share price
-0.28%
Change (1 day)
-6.31%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): $4.08

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.06. In 2022 the company made an earnings per share (EPS) of $3.95 a decrease over its 2021 EPS that were of $4.70.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$4.083.27%
2022$3.95-15.84%
2021$4.7012.77%
2020$4.1770.79%
2019$2.4415.63%
2018$2.11-33.13%
2017$3.15141.17%
2016$1.318.28%
2015$1.2111.28%
2014$1.0916.37%
2013$0.93-67.42%
2012$2.8684.22%
2011$1.5562.13%
2010$0.9680.61%
2009$0.53-559.63%
2008-$0.12-123.16%
2007$0.50